ARQT Overview
Upcoming Projects (ARQT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ARQT)
-
Getting a community dermatologist's perspective on plaque psoriasis non-steroid topical treatments including Roivant's VTAMA (tapinarof) and Arcutis' Zoryve (roflumilast)
Tickers: ROIV, ARQT, INCY
Executed On: Mar 07, 2023 at 01:00 PM EST -
Examining Arcutis Bio’s Lead Pipeline Drug, ARQ-154 (Foam Roflumilast), as a Potential Treatment for Scalp and Body Psoriasis
Ticker: ARQT
Executed On: Nov 03, 2022 at 09:00 AM EDT -
Discussing therapies in development for plaque psoriasis with a focus on Dermavant VTAMA (tapinarof) cream and Arcutis' ZORYVE
Tickers: ROIV, ARQT
Executed On: Nov 01, 2022 at 01:00 PM EDT -
Discussing Arcutis' roflumilast vs. Dermavant's tapinatof for the treatment of psoriasis
Tickers: ARQT, ROIV
Executed On: Jun 09, 2022 at 01:00 PM EDT
Upcoming & Overdue Catalysts (ARQT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ARQT)
-
Arcutis Bio (ARQT) Announces Topline Data from Phase 2b Study of ARQ-154 (Topical Roflumilast Foam) in Treating Scalp and Body Psoriasis
Ticker: ARQT
Occurred on: Nov 23, 2020
Strategic Initiatives (ARQT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
